Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

FTDP-17: 2-year follow-up of motor and cognitive features after autologous stem-cell transplantation.

Larner AJ.

J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):E1-2. doi: 10.1176/appi.neuropsych.11030075. No abstract available.

PMID:
22772676
2.

The principles and overview of autologous hematopoietic stem cell transplantation.

Vaughan W, Seshadri T, Bridges M, Keating A.

Cancer Treat Res. 2009;144:23-45. doi: 10.1007/978-0-387-78580-6_2. Review. No abstract available.

PMID:
19779877
3.

The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation.

Hjermstad MJ, Loge JH, Evensen SA, Kvaløy SO, Fayers PM, Kaasa S.

Bone Marrow Transplant. 1999 Dec;24(11):1219-28.

4.

The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients.

Beglinger LJ, Mills JA, Vik SM, Duff K, Denburg NL, Weckmann MT, Paulsen JS, Gingrich R.

Arch Clin Neuropsychol. 2011 Mar;26(2):98-109. doi: 10.1093/arclin/acq103. Epub 2010 Dec 23.

5.

Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.

Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A, Kunze S, Balck F, Bornhäuser M, Ehninger G, Dolan K, Gramatzki M, Kolb HJ, Heußner P, Wilhelm H, Beelen DW, Schulz-Kindermann F, Zander AR, Koch U, Mehnert A.

Psychooncology. 2013 Jul;22(7):1509-16. doi: 10.1002/pon.3159. Epub 2012 Sep 4.

PMID:
22945857
6.

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.

Shevchenko JL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kurbatova KA, Gorodokin GI, Novik AA.

Ann Hematol. 2015 Jul;94(7):1149-57. doi: 10.1007/s00277-015-2337-8. Epub 2015 Feb 25.

PMID:
25711670
7.

Comparing neurocognition in severe chronic schizophrenia and frontotemporal dementia.

Chan HM, Stolwyk R, Kelso W, Neath J, Walterfang M, Mocellin R, Pavlis A, Velakoulis D.

Aust N Z J Psychiatry. 2014 Sep;48(9):828-37. doi: 10.1177/0004867414529477. Epub 2014 Apr 7.

PMID:
24711578
8.

Should the Social Cognition and Emotional Assessment replace standard neuropsychological tests for frontotemporal dementia?

Sarazin M, Dubois B, de Souza LC, Bertoux M.

Expert Rev Neurother. 2012 Jun;12(6):633-5. doi: 10.1586/ern.12.46. No abstract available.

PMID:
22650163
9.

Autologous stem cell transplantation for POEMS syndrome.

Nakaseko C.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):21-3. doi: 10.1016/j.clml.2013.12.009. Epub 2013 Dec 22. No abstract available.

PMID:
24461808
10.

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

Gahrton G, Iacobelli S, Björkstrand B, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Carella AM, Beksac M, Bosi A, Milone G, Corradini P, Schönland S, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Garderet L, Kröger N; EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee..

Blood. 2013 Jun 20;121(25):5055-63. doi: 10.1182/blood-2012-11-469452. Epub 2013 Mar 12.

11.
12.

Multiple myeloma in a 50-year-old with an HLA-identical sibling.

Koreth J.

Biol Blood Marrow Transplant. 2007 Oct;13(10):1247-8. No abstract available.

13.

Motor neuron disease-frontotemporal dementia: a clinical continuum.

Devenney E, Vucic S, Hodges JR, Kiernan MC.

Expert Rev Neurother. 2015 May;15(5):509-22. doi: 10.1586/14737175.2015.1034108. Epub 2015 Apr 11. Review.

PMID:
25865485
14.

Autologous haematopoietic stem cell transplantation.

Mancardi GL.

Neurol Sci. 2005 May;26 Suppl 1:S19. Review. No abstract available.

PMID:
15883681
15.

Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.

Porter DL, Hexner EO, Cooley S, Miller JS.

Cancer Treat Res. 2009;144:497-537. doi: 10.1007/978-0-387-78580-6_20. Review. No abstract available.

PMID:
19779876
16.

Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis.

Gosselin D, Rivest S.

Neurotherapeutics. 2011 Oct;8(4):643-9. doi: 10.1007/s13311-011-0062-0. Review.

17.

Autologous haematopoietic stem-cell transplantation in multiple sclerosis.

Mancardi G, Saccardi R.

Lancet Neurol. 2008 Jul;7(7):626-36. doi: 10.1016/S1474-4422(08)70138-8. Review.

PMID:
18565456
18.
20.

Diminished T-cell recovery after CD34(+) selected autologous peripheral blood stem cell transplantation increases the risk of cytomegalovirus infection.

Nishio M, Koizumi K, Endo T, Fujimoto K, Koike T, Sawada K.

Haematologica. 2001 Jun;86(6):667-8. No abstract available.

Supplemental Content

Support Center